DELIVERY ORDER
Active75N93026F00001
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH NIAID
$347.8K
obligated · signed 4 months ago
EO 14398 - PCMID A17 - MODEL DEVELOPMENT AND IN VIVO SCREENING OF ANTIVIRALS DIRECTED AGAINST SELECT TOGAVIRUSES
Performance timeline
Start
Jun 1, 2026
End
May 31, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: May 31, 2027
UNIVERSITY OF TENNESSEE
Contract 75N93026F00001
UEI
X1M1PN3KG3E7
Parent Company
UNIVERSITY OF TENNESSEE
Capabilities & Certifications
Headquarters Location
Congressional District: 09
Current Obligation
$347,823
Base + Exercised Options
$347,823
Total Ceiling Value
$986,717
Contract Type
COST NO FEE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Place of Performance
Congressional District: 09
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Contract Vehicle
75N93024D00028
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.